Clover Health is being bought and sold at more than $15 a share, about double its value of $7.64 at the end of May, according to the Journal. During premarket trading June 8, the stock was up another 30 percent from the day prior. Additionally, 125 million shares were traded June 8, which is almost an eightfold increase from June 4, according to the Journal.
Some Reddit users are likening Clover’s gains to AMC and GameStop. One user wrote June 8 that for those “who missed on $GME! Listen up, $CLOV is ready to lift off!” according to the report. Still, shares of AMC and GameStop are up nearly 2,500 percent and 1,400 percent, respectively, while Clover is down 29 percent this year.
Clover is also facing allegations from Hindenburg Research that the company misled investors, though Clover’s management disputed the report, according to the Journal.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
